NGS Sample Preparation Market Developments, Growth and 2019 - 2027 Forecast Rese

Posted by Aniket Ankushrao on July 8th, 2019

NGS Sample Preparation Market Introduction:

Next Generation Sequencing (NGS) is a genome analysis platform which is more affordable, rapid and accurate. NGS is built upon first generation sequencing technologies to generate accurate and cost-effective results of sequencing. Next generation sequencing is a powerful platform which has made it possible to simultaneously sequence thousands to millions of DNA molecules. This powerful tool is revolutionizing areas such as genetic diseases, personalized medicine, and clinical diagnostics by providing a high throughput option with the capability for sequencing multiple individuals at the same time.

All NSG platforms need a library which can be prepared by generating a collection of DNA fragments for the sequencing. NGS libraries are generally prepared by fragmenting a sample of genomic DNA and ligating both fragment ends with specialized adapters. These adapter sequences provide a universal priming site to sequence primers by allowing for library hybridization to the sequencing chips. An alternative process called tagmentation constitutes a combination of fragmentation and ligation reactions into a single step. These adapter-ligated fragments are later PCR amplified and gel purified.

NGS Sample Preparation Market – Competition Landscape

Rise in adoption of genomics for developing innovative diagnostic tools and tests and development of precision & personalized medicines has led to surge in collaboration among NGS tools & service providers and diagnostic & pharmaceutical companies. For an instance, in June 2017, Bristol-Myers Squibb Company and QIAGEN entered into an agreement for development gene expression profiles (GEPs) using NGS technology for former’s immuno-oncology (I-O) therapies in cancer treatment. In 2017, Illumina partnered with China’s KingMed Diagnostics to use its NGS technology for oncology and genetic disease testing.

Illumina, Inc.:

The US based, Illumina, Inc. is a manufacturer and provider of life science solutions with focus on gene sequencing and analysis. It is one of the leading supplier for NGS sample preparation tools. Illumina, Inc. is pioneer in providing affordable NGS platforms for researchers.

Agilent Technologies, Inc.:

Company offers its NGS sample preparation solutions under its Diagnostics and Genomics Group. Agilent has adopted inorgcanic growth strategies to expand its NGS solutions portfolio, for an instance company has acquired Lasergen which was engaged in development of DNA sequencing technologies, in 2017, Agilent acquired molecular and sample barcoding patents from Population Genetics Technologies. In February 2019, Agilent Technologies launched its NGS library preparation systems designed specifically to run complex DNA sequencing assays.

Other key players operating in the in the global NGS sample preparation market include Thermo Fisher Scientific, QIAGEN, BD, Pacific Biosciences of California, Inc., 10x Genomics, F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies, and Eurofins Scientific. These players have adopted strategies such as agreements, partnerships, new product development, and collaborations to gain competitive advantage in the global NGS sample preparation market.

NGS Sample Preparation Market Dynamics

Increase in application of NGS in genomics and diagnostic research -

NGS tools manufacturers and service providing companies are collaborating on development of innovative and more precise diagnostic tools. Genetic testing is advancing its application in pre-diagnosis of various chronic and genetic diseases such as cancer, diabetes, certain neural disorders and others. As the demand for quality healthcare and preventive diagnostics is likely to surge it is anticipated to augment the use of NGS technique, thereby propelling the NGS sample preparation market.

Request Brochure of the Report:

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=68159

Accurate, Rapid and Affordable Platforms for Gene Sequencing & Analysis -

NGS offers accurate and rapid gene sequencing and analysis for researchers. As the adoption for genetics in healthcare and other life sciences related industries is growing, more and more players are introducing their products and services for NGS sample preparation. With the surge in number of suppliers, the cost for NGS sample preparation is likely to decline. Further key players are striving to introduce more affordable and accurate NGS solutions. For an instance, in 2014 Agilent Technologies, Inc. launched its HiSeq X10 NGS platform which made NGS affordable to many researchers across the globe, its recent introduction of NovaSeq NGS platform is likely to revolutionize the NGS processes by further reducing the procedure costs.